STK35 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.557200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.543900E-02
Normal-vs-Stage2
5.621800E-01
Normal-vs-Stage3
3.808600E-01
Normal-vs-Stage4
4.212800E-01
Stage1-vs-Stage2
3.216000E-01
Stage1-vs-Stage3
2.230200E-02
Stage1-vs-Stage4
6.088000E-01
Stage2-vs-Stage3
8.928200E-02
Stage2-vs-Stage4
7.475200E-01
Stage3-vs-Stage4
1.479190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.949000E-01
Normal-vs-AfricanAmerican
3.356400E-01
Normal-vs-Asian
6.277400E-01
Caucasian-vs-AfricanAmerican
9.936600E-01
Caucasian-vs-Asian
3.094400E-02
AfricanAmerican-vs-Asian
1.256380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.662000E-01
Normal-vs-Female
5.342400E-01
Male-vs-Female
9.757800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.045600E-01
Normal-vs-Age(41-60Yrs)
2.529600E-01
Normal-vs-Age(61-80Yrs)
7.013400E-01
Normal-vs-Age(81-100Yrs)
8.252200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.317400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.665200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.234600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.708030E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.515230E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.512400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.919400E-01
Normal-vs-Daily Drinker
5.727000E-01
Normal-vs-Weekly Drinker
6.723000E-01
Normal-vs-Occasional Drinker
8.693700E-02
Normal-vs-Social Drinker
3.900200E-01
Non Drinker-vs-Daily Drinker
3.697000E-01
Non Drinker-vs-Weekly Drinker
6.579000E-01
Non Drinker-vs-Occasional Drinker
1.891960E-02
Non Drinker-vs-Social Drinker
2.371600E-01
Daily Drinker-vs-Weekly Drinker
7.182400E-01
Daily Drinker-vs-Occasional Drinker
2.266800E-01
Daily Drinker-vs-Social Drinker
7.343400E-01
Weekly Drinker-vs-Occasional Drinker
1.021640E-01
Weekly Drinker-vs-Social Drinker
4.799600E-01
Occasional Drinker-vs-Social Drinker
4.161800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.895800E-01
Normal-vs-Grade 2
7.793400E-01
Normal-vs-Grade 3
3.226000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.623800E-01
Grade 1-vs-Grade 3
4.852200E-01
Grade 1-vs-Grade 4
4.895800E-01
Grade 2-vs-Grade 3
2.815800E-01
Grade 2-vs-Grade 4
7.793400E-01
Grade 3-vs-Grade 4
3.226000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.488800E-01
Normal-vs-NonDiabetic
5.317800E-01
Diabetic-vs-NonDiabetic
1.481030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.851600E-01
Normal-vs-NoPancreatitis
5.927000E-01
Pancreatitis-vs-NoPancreatitis
8.769200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.755200E-01
Normal-vs-N1
5.616000E-01
N0-vs-N1
8.027800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.592400E-01
Normal-vs-TP53-NonMutant
6.261800E-01
TP53-Mutant-vs-TP53-NonMutant
2.108400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
